Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Attention-deficit hyperactivity disorder controversies Stories

2010-08-27 08:14:07

(Ivanhoe Newswire) -- Adults with attention-deficit/hyperactive disorder (ADHD) are showing greater improvement when receiving individual sessions of cognitive behavioral therapy (CBT) in addition to their monthly medication. "Approximately 4.4 percent of adults in the United States with ADHD, which is a disorder characterized by impairing levels of inattention, hyperactivity, and impulsivity. Medications have been the primary treatment; however, many adults with ADHD cannot or will not take...

2010-08-25 01:56:13

Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA. "Approximately 4.4 percent of adults in the United States have ADHD, which is a disorder characterized by impairing levels of inattention, hyperactivity, and impulsivity. Medications have been...

2010-08-25 01:52:29

Skills-based treatment added to medication helps patients handle persistent symptoms Adding cognitive behavioral therapy "“ an approach that teaches skills for handling life challenges and revising negative thought patterns "“ to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients. The report from Massachusetts General Hospital (MGH) researchers appear in the August 25 Journal of the...

2010-08-23 07:05:00

NEW YORK, Aug. 23 /PRNewswire/ -- A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes. The study, "The Effect of Hemispheric Specific Remediation Strategies on the Academic Performance Outcome of Children With ADD/ADHD," was conducted by a research team including, Gerry Leisman, Robert Melillo, Sharon Thum, Mark Ransom, Michael Orlando, Christopher Tice, and Frederick Carrick. The study appears in the current...

ad7ac592f99bb46d52ca501e6447f8d91
2010-08-18 08:35:00

Nearly 1 million children in the United States are potentially misdiagnosed with attention deficit hyperactivity disorder simply because they are the youngest "“ and most immature "“ in their kindergarten class, according to new research by a Michigan State University economist. These children are significantly more likely than their older classmates to be prescribed behavior-modifying stimulants such as Ritalin, said Todd Elder, whose study will appear in a forthcoming issue of...

2010-08-18 10:00:00

Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth. "The question we asked was whether children who are relatively young compared to their classroom...

2010-07-21 13:11:17

A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children. Published online, ahead of print, in the journal Environmental Health Perspectives, the researchers found "increased odds of ADHD in children with higher serum PFC levels." The researchers used data from the National...

2010-07-06 16:00:00

DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12...

7913edf43328c6670895a128a70e46031
2010-06-19 07:40:57

A new study published online in the Journal of Pediatrics suggests that neither attention deficit hyperactivity disorder (ADHD) nor medications used to treat it have a long-term impact on kids' growth. Previous studies have shown that medication may make kids with ADHD eat less and grow slower than their peers that do not have the condition.  According to the Center for Disease Control and Prevention, about 10 percent of boys and 6 percent of girl shave been diagnosed with ADHD. "There...

2010-06-01 19:14:13

Study covered 1.16 million children aged 6 to 19 A major study of more than a million children has found strong links between receiving medication for attention deficit hyperactivity disorder (ADHD) and limited maternal education, single parent families and welfare benefits, according to the June issue of Acta Paediatrica. Swedish experts teamed up to carry out what they believe is the first study of risk factors for ADHD in a national cohort of school children, based on 1.16 million children...